# Nasal Mucin Oral Supplementation Treatment Respiratory Inflammation Using PUFA in Cystic Fibrosis (CF) Patients

> **NCT01329172** · NA · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 7 (actual)

## Conditions studied

- Cystic Fibrosis
- Dietary Modification

## Interventions

- **OTHER:** polyunsaturated fatty acids n-3
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01329172
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09-20
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2017-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01329172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01329172, "Nasal Mucin Oral Supplementation Treatment Respiratory Inflammation Using PUFA in Cystic Fibrosis (CF) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01329172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*